[{"address1": "302 East Pettigrew St.", "address2": "Suite A-100", "city": "Durham", "state": "NC", "zip": "27701", "country": "United States", "phone": "919 314 5512", "fax": "480 393 5553", "website": "https://precisionbiosciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-3243 for the treatment of m.3243 associated mitochondrial myopathy. In addition, the company develops PBGENE-NVS (insertion) for sickle cell and beta thalassemia diseases; PBGENE-DMD (excision) for duchenne muscular dystrophy; PBGENE-LIVER (insertion), a liver directed target; PBGENE-CNS (excision), a central nervous system directed target; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with Novartis Pharma AG to discover and develop in vivo gene editing products; TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; and iECURE, Inc. to develop ARCUS-based gene-insertion therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.", "fullTimeEmployees": 67, "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael  Amoroso", "age": 46, "title": "President, CEO & Director", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 1094351, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jefferson J. Smith Ph.D.", "age": 51, "title": "Co-Founder & Chief Research Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 640195, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Alexander Kelly R.Ph.", "age": 57, "title": "CFO & Principal Accounting Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 671382, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cassie  Gorsuch Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Naresh  Tanna", "title": "Chief of Staff to CEO & Head of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dario  Scimeca J.D.", "age": 49, "title": "General Counsel & Secretary", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 576432, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Juli  Blanche", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cindy  Atwell", "title": "Chief Development & Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Neil  Leatherbury M.S.", "title": "Senior VP and Head of Chemistry, Manufacturing & Controls", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 9, "overallRisk": 7, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.52, "open": 4.53, "dayLow": 4.37, "dayHigh": 4.638, "regularMarketPreviousClose": 4.52, "regularMarketOpen": 4.53, "regularMarketDayLow": 4.37, "regularMarketDayHigh": 4.638, "payoutRatio": 0.0, "beta": 1.112, "forwardPE": -1.4437299, "volume": 563460, "regularMarketVolume": 563460, "averageVolume": 190226, "averageVolume10days": 193260, "averageDailyVolume10Day": 193260, "bid": 4.91, "ask": 5.05, "bidSize": 1, "askSize": 1, "marketCap": 108082160, "fiftyTwoWeekLow": 3.61, "fiftyTwoWeekHigh": 8.82, "allTimeHigh": 710.1, "allTimeLow": 3.61, "priceToSalesTrailing12Months": 154.8455, "fiftyDayAverage": 5.9076, "twoHundredDayAverage": 5.158875, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 43780812, "profitMargins": 0.0, "floatShares": 12564881, "sharesOutstanding": 24071751, "sharesShort": 636655, "sharesShortPriorMonth": 485968, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.026400002, "heldPercentInsiders": 0.05868, "heldPercentInstitutions": 0.23637, "shortRatio": 2.58, "shortPercentOfFloat": 0.026800001, "impliedSharesOutstanding": 24071751, "bookValue": 1.377, "priceToBook": 3.2607117, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -83602000, "trailingEps": -8.96, "forwardEps": -3.11, "lastSplitFactor": "1:30", "lastSplitDate": 1707868800, "enterpriseToRevenue": 62.723, "enterpriseToEbitda": -0.498, "52WeekChange": 0.00444448, "SandP52WeekChange": 0.1340276, "quoteType": "EQUITY", "currentPrice": 4.49, "targetHighPrice": 60.0, "targetLowPrice": 19.0, "targetMeanPrice": 32.5, "targetMedianPrice": 25.5, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 44870000, "totalCashPerShare": 3.385, "ebitda": -87925000, "totalDebt": 29128000, "quickRatio": 2.992, "currentRatio": 3.448, "totalRevenue": 698000, "debtToEquity": 175.111, "revenuePerShare": 0.069, "returnOnAssets": -0.45337, "returnOnEquity": -2.05158, "grossProfits": 698000, "freeCashflow": -37418000, "operatingCashflow": -73276000, "revenueGrowth": -0.977, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -1589.7692, "financialCurrency": "USD", "symbol": "DTIL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Precision BioSciences, Inc.", "longName": "Precision BioSciences, Inc.", "postMarketChangePercent": 0.44544452, "postMarketPrice": 4.51, "postMarketChange": 0.020000458, "regularMarketChange": -0.0300002, "regularMarketDayRange": "4.37 - 4.638", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 190226, "fiftyTwoWeekLowChange": 0.8799999, "fiftyTwoWeekLowChangePercent": 0.24376729, "fiftyTwoWeekRange": "3.61 - 8.82", "fiftyTwoWeekHighChange": -4.33, "fiftyTwoWeekHighChangePercent": -0.49092972, "fiftyTwoWeekChangePercent": 0.444448, "earningsTimestamp": 1762176600, "earningsTimestampStart": 1762176600, "earningsTimestampEnd": 1762176600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -8.96, "epsForward": -3.11, "epsCurrentYear": -6.16333, "messageBoardId": "finmb_41018856", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "priceEpsCurrentYear": -0.7285022, "fiftyDayAverageChange": -1.4176002, "fiftyDayAverageChangePercent": -0.23996212, "twoHundredDayAverageChange": -0.6688752, "twoHundredDayAverageChangePercent": -0.12965524, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -0.663721, "regularMarketPrice": 4.49, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1553779800000, "corporateActions": [], "postMarketTime": 1766191344, "regularMarketTime": 1766178003, "exchange": "NCM", "marketState": "CLOSED", "displayName": "Precision BioSciences", "trailingPegRatio": null, "__fetch_time": "2025-12-20"}]